Liraglutide for weight management: a critical review of the evidence

por Mehta, A., Marso, S. P., Neeland, I. J.
Publicado 2016

Changes in Heart Rate Associated with Exenatide Once Weekly: Pooled Analysis of Clinical Data in Patients with Type 2 Diabetes

por Marso, Steven P., Hardy, Elise, Han, Jenny, Wang, Hui, Chilton, Robert J.
Publicado 2018

Cardiovascular outcomes in patients who experienced a myocardial infarction while treated with liraglutide versus placebo in the LEADER trial

por Nauck, Michael A, Tornøe, Karen, Rasmussen, Søren, Treppendahl, Marianne Bach, Marso, Steven P
Publicado 2018

Liraglutide and cardiovascular outcomes in adults with overweight or obesity: A post hoc analysis from SCALE randomized controlled trials

por Davies, M. J., Aronne, L. J., Caterson, I. D., Thomsen, A. B., Jacobsen, P. B., Marso, S. P.
Publicado 2017

DEVOTE 5: Evaluating the Short-Term Cost-Utility of Insulin Degludec Versus Insulin Glargine U100 in Basal–Bolus Regimens for Type 2 Diabetes in the UK

por Pollock, Richard F., Valentine, William J., Marso, Steven P., Gundgaard, Jens, Hallén, Nino, Hansen, Lars L., Tutkunkardas, Deniz, Buse, John B.
Publicado 2018

Long-term Cost-effectiveness of Insulin Degludec Versus Insulin Glargine U100 in the UK: Evidence from the Basal-bolus Subgroup of the DEVOTE Trial (DEVOTE 16)

por Pollock, Richard F., Valentine, William J., Marso, Steven P., Andersen, Andreas, Gundgaard, Jens, Hallén, Nino, Tutkunkardas, Deniz, Magnuson, Elizabeth A., Buse, John B.
Publicado 2019

LEADER 7: cardiovascular risk profiles of US and European participants in the LEADER diabetes trial differ

por Rutten, Guy E. H. M., Tack, Cees J., Pieber, Thomas R., Comlekci, Abdurrahman, Ørsted, David Dynnes, Baeres, Florian M. M., Marso, Steven P., Buse, John B.
Publicado 2016

LEADER 5: prevalence and cardiometabolic impact of obesity in cardiovascular high-risk patients with type 2 diabetes mellitus: baseline global data from the LEADER trial

por Masmiquel, L., Leiter, L. A., Vidal, J., Bain, S., Petrie, J., Franek, E., Raz, I., Comlekci, A., Jacob, S., van Gaal, L., Baeres, F. M. M., Marso, S. P., Eriksson, M.
Publicado 2016

LEADER 2: baseline calcitonin in 9340 people with type 2 diabetes enrolled in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results (LEADER) t...

por Daniels, G H, Hegedüs, L, Marso, S P, Nauck, M A, Zinman, B, Bergenstal, R M, Mann, J F E, Derving Karsbøl, J, Moses, A C, Buse, J B, Tuttle, R M
Publicado 2015

Effect of Mineralocorticoid Receptor Antagonists on Cardiac Structure and Function in Patients With Diastolic Dysfunction and Heart Failure With Preserved Ejection Fraction: A Meta...

por Pandey, Ambarish, Garg, Sushil, Matulevicius, Susan A., Shah, Amil M., Garg, Jalaj, Drazner, Mark H., Amin, Alpesh, Berry, Jarett D., Marwick, Thomas H., Marso, Steven P., de Lemos, James A., Kumbhani, Dharam J.
Publicado 2015

Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2)

por Zinman, Bernard, Marso, Steven P., Poulter, Neil R., Emerson, Scott S., Pieber, Thomas R., Pratley, Richard E., Lange, Martin, Brown-Frandsen, Kirstine, Moses, Alan, Ocampo Francisco, Ann Marie, Barner Lekdorf, Jesper, Kvist, Kajsa, Buse, John B.
Publicado 2017

Cardiovascular safety and lower severe hypoglycaemia of insulin degludec versus insulin glargine U100 in patients with type 2 diabetes aged 65 years or older: Results from DEVOTE (...

por Pratley, Richard E., Emerson, Scott S., Franek, Edward, Gilbert, Matthew P., Marso, Steven P., McGuire, Darren K., Pieber, Thomas R., Zinman, Bernard, Hansen, Charlotte T., Hansen, Melissa V., Mark, Thomas, Moses, Alan C., Buse, John B.
Publicado 2019

Risk of severe hypoglycaemia and its impact in type 2 diabetes in DEVOTE

por Heller, Simon, Lingvay, Ildiko, Marso, Steven P., Philis‐Tsimikas, Athena, Pieber, Thomas R., Poulter, Neil R., Pratley, Richard E., Hachmann‐Nielsen, Elise, Kvist, Kajsa, Lange, Martin, Moses, Alan C., Andresen, Marie Trock, Buse, John B.
Publicado 2020

Development of a hypoglycaemia risk score to identify high‐risk individuals with advanced type 2 diabetes in DEVOTE

por Heller, Simon, Lingvay, Ildiko, Marso, Steven P., Philis‐Tsimikas, Athena, Pieber, Thomas R., Poulter, Neil R., Pratley, Richard E., Hachmann‐Nielsen, Elise, Kvist, Kajsa, Lange, Martin, Moses, Alan C., Trock Andresen, Marie, Buse, John B.
Publicado 2020

LEADER 3—Lipase and Amylase Activity in Subjects With Type 2 Diabetes: Baseline Data From Over 9000 Subjects in the LEADER Trial

por Steinberg, William M., Nauck, Michael A., Zinman, Bernard, Daniels, Gilbert H., Bergenstal, Richard M., Mann, Johannes F.E., Steen Ravn, Lasse, Moses, Alan C., Stockner, Mette, Baeres, Florian M.M., Marso, Steven P., Buse, John B.
Publicado 2014

Semaglutide for cardiovascular event reduction in people with overweight or obesity: SELECT study baseline characteristics

por Lingvay, Ildiko, Brown‐Frandsen, Kirstine, Colhoun, Helen M., Deanfield, John, Emerson, Scott S., Esbjerg, Sille, Hardt‐Lindberg, Søren, Hovingh, G. Kees, Kahn, Steven E., Kushner, Robert F., Lincoff, A. Michael, Marso, Steven P., Fries, Tea Monk, Plutzky, Jorge, Ryan, Donna H.
Publicado 2022

LEADER-4: blood pressure control in patients with type 2 diabetes and high cardiovascular risk: baseline data from the LEADER randomized trial

por Petrie, John R., Marso, Steven P., Bain, Stephen C., Franek, Edward, Jacob, Stephan, Masmiquel, Luis, Leiter, Lawrence A., Haluzik, Martin, Satman, Ilhan, Omar, Mohamed, Shestakova, Marina, Van Gaal, Luc, Mann, Johannes F., Baeres, Florian M.M., Zinman, Bernard, Poulter, Neil R.
Publicado 2016

DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality

por Pieber, Thomas R., Marso, Steven P., McGuire, Darren K., Zinman, Bernard, Poulter, Neil R., Emerson, Scott S., Pratley, Richard E., Woo, Vincent, Heller, Simon, Lange, Martin, Brown-Frandsen, Kirstine, Moses, Alan, Barner Lekdorf, Jesper, Lehmann, Lucine, Kvist, Kajsa, Buse, John B.
Publicado 2017